Ellen M. K. Warlo

Genetic Variation in ADAMTS13 is Related to VWF Levels, Atrial Fibrillation and Cerebral Ischemic Events

H. Arnesen, T. Opstad, I. Seljeflot, 2022, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease

H. Arnesen, I. Seljeflot, A. Pettersen, 2017, Thrombosis Journal.

A brief review on resistance to P2Y12 receptor antagonism in coronary artery disease

H. Arnesen, I. Seljeflot, E. M. K. Warlo, 2019, Thrombosis Journal.

von Willebrand factor, ADAMTS-13, and thrombospondin 1 in relation to clinical outcomes in elderly patients with a recent myocardial infarction

A. Tveit, H. Arnesen, S. Solheim, 2023, Research and practice in thrombosis and haemostasis.